Senate Bill 95 allocates $300,000 to the Department of Public Health and Human Services for the biennium beginning July 1, 2025. This funding is dedicated to suicide prevention efforts specifically for service members, veterans, and their families. The bill outlines several key uses for the money, including implementing prevention strategies and establishing screening standards for suicide risk. It also aims to improve care transitions and increase lethal means safety through initiatives such as a statewide safe storage campaign and training events. The act is effective July 1, 2025, and terminates on June 30, 2027.
SB 218 establishes a private right of action, allowing minors, their legal guardians, or estates to file civil lawsuits against healthcare professionals and physicians. These lawsuits can be brought for injuries caused by specific medical interventions, including certain surgeries, hormone therapies, and puberty blockers, when provided to minors to treat gender dysphoria. Liability may arise if the injury is proximately caused by a deviation from the applicable medical standard of care. The bill sets a statute of limitations for these actions and clarifies that it does not apply to treatments for medically verifiable disorders of sex development or complications from prior medical treatments.
HB 740 revises laws affecting pharmacies, pharmacy benefit managers (PBMs), and other entities involved in prescription drug dispensing and reimbursement. The bill establishes new restrictions on how PBMs can audit pharmacies and recoup funds, such as prohibiting recoupment for clerical errors without actual financial harm and banning the use of extrapolation in calculations. It also updates regulations for Maximum Allowable Cost (MAC) lists and reference pricing, requiring PBMs to ensure drugs on MAC lists are available and to frequently update and disclose pricing information to pharmacies.
HB 687 revises the age range for expanded Medicaid participants who are required to engage in community engagement activities. Previously, participants aged 19 to 55 were subject to this requirement. This bill extends that upper age limit, now requiring individuals from 19 to 62 years old to participate. Affected participants must complete 80 hours per month in activities such as employment, education, work training, or community service, unless they qualify for an exemption. This change directly impacts expanded Medicaid recipients between the ages of 56 and 62.
SJ 49 requests an interim study of youth and family behavioral health prevention programs across Montana. An interim committee will be designated to comprehensively review these programs, focusing on their funding, workforce, and delivery settings for youth under 18. The study aims to identify gaps in the state's behavioral health system and assess how prevention efforts divert youth and families from crises, with findings to be reported to the 70th Legislature.
HB 600 authorizes public and nonpublic schools to maintain a supply of "stock albuterol," a quick-relief asthma medication, for emergency use. This medication can be administered by a school nurse or other authorized school personnel to any individual, student or non-student, experiencing respiratory distress on school grounds or at school-related activities. Schools choosing to keep stock albuterol must develop a protocol for staff training, medication maintenance, and post-administration follow-up, including determining when to make a 9-1-1 emergency call. The bill requires a prescription for the stock albuterol, with the school designated as the patient.
HB 607, known as the "Hearing Aid Coverage Act," proposes to expand health insurance coverage for hearing loss. The bill revises current law that mandates coverage only for children, extending this requirement to include individuals of all ages. It achieves this by amending sections 2-18-704 and 33-22-128 of the Montana Code Annotated, which govern mandatory provisions in insurance contracts. This change would require state insurance plans to cover treatment for hearing loss for both children and adults.
Senate Bill 495 eliminates the Tobacco Prevention Advisory Board. The bill repeals the specific section of law that established this board. It also amends existing statute to remove the board from the list of entities funded by state special revenue accounts, which are primarily used for tobacco disease prevention programs and the Children's Health Insurance Program. The direct effect is the dissolution of the advisory board, which previously provided guidance for these programs.
SB 211 revises the emergency use of epinephrine in school settings. The bill expands the definition of "medication" that students with asthma, severe allergies, or anaphylaxis can possess and self-administer to include epinephrine nasal spray. It also allows public and nonpublic schools to maintain a stock supply of epinephrine nasal spray, in addition to autoinjectable epinephrine, for emergency administration by school nurses or other authorized personnel. These changes provide schools with additional options for responding to severe allergic reactions.
This bill makes Montana's community health aide program permanent by removing its previously scheduled expiration date. It directs the Department of Public Health and Human Services to apply for Medicaid coverage for services provided by certified community health aides. The change directly affects community health aides and their patients, particularly in rural and tribal communities, ensuring continued access to essential healthcare services without future legislative renewal.
